Tumor heterogeneity in PCa elicited a complex molecular classification for patients.40 Compared with PCa tissue studies, top mutant genes, such as TP53 and SPOP, were not mutated in PCMR. The gene discussed is TP53; the disease is posterior cortical atrophy.